GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (LSE:OVB) » Definitions » Accounts Payable

Ovoca Bio (LSE:OVB) Accounts Payable : £0.38 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Ovoca Bio Accounts Payable?

Ovoca Bio's Accounts Payable for the quarter that ended in Jun. 2024 was £0.38 Mil.

Ovoca Bio's quarterly Accounts Payable declined from Jun. 2023 (£0.41 Mil) to Dec. 2023 (£0.26 Mil) but then increased from Dec. 2023 (£0.26 Mil) to Jun. 2024 (£0.38 Mil).

Ovoca Bio's annual Accounts Payable increased from Dec. 2021 (£0.32 Mil) to Dec. 2022 (£1.02 Mil) but then declined from Dec. 2022 (£1.02 Mil) to Dec. 2023 (£0.26 Mil).


Ovoca Bio Accounts Payable Historical Data

The historical data trend for Ovoca Bio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Accounts Payable Chart

Ovoca Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.32 0.32 1.02 0.26

Ovoca Bio Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.02 0.41 0.26 0.38

Ovoca Bio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Ovoca Bio Accounts Payable Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovoca Bio Business Description

Traded in Other Exchanges
Address
17 Pembroke Street Upper, Dublin, IRL, D02 AT22
Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio Headlines

From GuruFocus

Overlay Shares Reach 5-Year Track Record

By PRNewswire 10-03-2024

Overlay Shares Core Bond ETF Crosses $100 Million in Assets

By PRNewswire PRNewswire 07-09-2020

Top 5 2nd Quarter Trades of Advocacy Wealth Management Services, LLC

By GuruFocus Research GuruFocus Editor 07-06-2022

Overlay Shares Launch New ETFs and Cross $300 Million in Assets

By PRNewswire PRNewswire 01-21-2021

Overlay Shares Cross $500 Million in Assets

By PRNewswire PRNewswire 02-01-2022